Efficacy of a new local limb salvage treatment for limb-threatening diabetic foot wounds - a randomized controlled study

Mostafa Yakoot,1 Mahmoud Abdelatif,2 Sherine Helmy31Internal Medicine Department, Green Clinic and Research Center, Alexandria, Egypt; 2General Surgery Department, Alexandria Health Insurance Hospitals, Alexandria, Egypt; 3Research and Innovations, Pharco Corporate, Alexandria, EgyptCorrespondence:...

Descripción completa

Guardado en:
Detalles Bibliográficos
Autores principales: Yakoot M, Abdelatif M, Helmy S
Formato: article
Lenguaje:EN
Publicado: Dove Medical Press 2019
Materias:
Acceso en línea:https://doaj.org/article/bbc9776ac0ff4d17962e698598db7ebf
Etiquetas: Agregar Etiqueta
Sin Etiquetas, Sea el primero en etiquetar este registro!
id oai:doaj.org-article:bbc9776ac0ff4d17962e698598db7ebf
record_format dspace
spelling oai:doaj.org-article:bbc9776ac0ff4d17962e698598db7ebf2021-12-02T02:18:21ZEfficacy of a new local limb salvage treatment for limb-threatening diabetic foot wounds - a randomized controlled study1178-7007https://doaj.org/article/bbc9776ac0ff4d17962e698598db7ebf2019-09-01T00:00:00Zhttps://www.dovepress.com/efficacy-of-a-new-local-limb-salvage-treatment-for-limb-threatening-di-peer-reviewed-article-DMSOhttps://doaj.org/toc/1178-7007Mostafa Yakoot,1 Mahmoud Abdelatif,2 Sherine Helmy31Internal Medicine Department, Green Clinic and Research Center, Alexandria, Egypt; 2General Surgery Department, Alexandria Health Insurance Hospitals, Alexandria, Egypt; 3Research and Innovations, Pharco Corporate, Alexandria, EgyptCorrespondence: Mostafa YakootInternal Medicine Department, Green Clinic and Research Center, Alexandria 21121, EgyptTel +20 3 391 3725Email yakoot@yahoo.comBackground: Diabetic foot ulcer (DFU) is the main risk factor for nontraumatic lower-limb amputation. We hypothesized that by reversing the offending local tissue factors resulting from the low tissue supply of oxygen, inefficient fuel metabolism and acidosis, we can eradicate the infection and help to promote healing. This might be enhanced with the help of an innovated local preparation (PEDYPHAR®,) through its enriched alkaline ointment base and the regenerating growth factors of Royal Jelly (RJ) plus the antimicrobial, immune-modulatory nutritional and other biochemical properties of RJ and Panthenol. We conducted this study to test the safety and efficacy of PEDYPHAR ointment as an adjuvant in limb salvage management for patients with limb-threatening diabetic foot wounds.Methods: A prospective, randomized, controlled open-label study design with a mean follow-up period of 12 weeks. One hundred and nineteen eligible patients with diabetic foot wounds presenting to 3 outpatient clinics in Egypt were randomized to be treated with the local application of either PEDYPHAR or Panthenol ointment under dressing after conservative debridement of necrotic tissue and irrigation with warm normal saline.Results: At the end of the 12-week follow-up period, PEDYPHAR showed a higher rate of complete healing of limb-threatening wounds in the intent-to-treat population, 11 of 34 (32.4%) in PEDYPHAR-treated group versus 3/25 (12%) in the Panthenol-treated (control) group (p=0.034* [*indicates it is statistically significant]).Conclusion: We can conclude that PEDYPHAR could be an effective and safe conservative local adjuvant treatment for cases of diabetic foot infection.Registration number in ClinicalTrials.gov: NCT01531517.Keywords: diabetic foot ulcers, limb threatening, local treatment, Royal Jelly, PanthenolYakoot MAbdelatif MHelmy SDove Medical Pressarticlediabetic foot ulcerslimb threateninglocal treatmentroyal jellypanthenol.Specialties of internal medicineRC581-951ENDiabetes, Metabolic Syndrome and Obesity: Targets and Therapy, Vol Volume 12, Pp 1659-1665 (2019)
institution DOAJ
collection DOAJ
language EN
topic diabetic foot ulcers
limb threatening
local treatment
royal jelly
panthenol.
Specialties of internal medicine
RC581-951
spellingShingle diabetic foot ulcers
limb threatening
local treatment
royal jelly
panthenol.
Specialties of internal medicine
RC581-951
Yakoot M
Abdelatif M
Helmy S
Efficacy of a new local limb salvage treatment for limb-threatening diabetic foot wounds - a randomized controlled study
description Mostafa Yakoot,1 Mahmoud Abdelatif,2 Sherine Helmy31Internal Medicine Department, Green Clinic and Research Center, Alexandria, Egypt; 2General Surgery Department, Alexandria Health Insurance Hospitals, Alexandria, Egypt; 3Research and Innovations, Pharco Corporate, Alexandria, EgyptCorrespondence: Mostafa YakootInternal Medicine Department, Green Clinic and Research Center, Alexandria 21121, EgyptTel +20 3 391 3725Email yakoot@yahoo.comBackground: Diabetic foot ulcer (DFU) is the main risk factor for nontraumatic lower-limb amputation. We hypothesized that by reversing the offending local tissue factors resulting from the low tissue supply of oxygen, inefficient fuel metabolism and acidosis, we can eradicate the infection and help to promote healing. This might be enhanced with the help of an innovated local preparation (PEDYPHAR®,) through its enriched alkaline ointment base and the regenerating growth factors of Royal Jelly (RJ) plus the antimicrobial, immune-modulatory nutritional and other biochemical properties of RJ and Panthenol. We conducted this study to test the safety and efficacy of PEDYPHAR ointment as an adjuvant in limb salvage management for patients with limb-threatening diabetic foot wounds.Methods: A prospective, randomized, controlled open-label study design with a mean follow-up period of 12 weeks. One hundred and nineteen eligible patients with diabetic foot wounds presenting to 3 outpatient clinics in Egypt were randomized to be treated with the local application of either PEDYPHAR or Panthenol ointment under dressing after conservative debridement of necrotic tissue and irrigation with warm normal saline.Results: At the end of the 12-week follow-up period, PEDYPHAR showed a higher rate of complete healing of limb-threatening wounds in the intent-to-treat population, 11 of 34 (32.4%) in PEDYPHAR-treated group versus 3/25 (12%) in the Panthenol-treated (control) group (p=0.034* [*indicates it is statistically significant]).Conclusion: We can conclude that PEDYPHAR could be an effective and safe conservative local adjuvant treatment for cases of diabetic foot infection.Registration number in ClinicalTrials.gov: NCT01531517.Keywords: diabetic foot ulcers, limb threatening, local treatment, Royal Jelly, Panthenol
format article
author Yakoot M
Abdelatif M
Helmy S
author_facet Yakoot M
Abdelatif M
Helmy S
author_sort Yakoot M
title Efficacy of a new local limb salvage treatment for limb-threatening diabetic foot wounds - a randomized controlled study
title_short Efficacy of a new local limb salvage treatment for limb-threatening diabetic foot wounds - a randomized controlled study
title_full Efficacy of a new local limb salvage treatment for limb-threatening diabetic foot wounds - a randomized controlled study
title_fullStr Efficacy of a new local limb salvage treatment for limb-threatening diabetic foot wounds - a randomized controlled study
title_full_unstemmed Efficacy of a new local limb salvage treatment for limb-threatening diabetic foot wounds - a randomized controlled study
title_sort efficacy of a new local limb salvage treatment for limb-threatening diabetic foot wounds - a randomized controlled study
publisher Dove Medical Press
publishDate 2019
url https://doaj.org/article/bbc9776ac0ff4d17962e698598db7ebf
work_keys_str_mv AT yakootm efficacyofanewlocallimbsalvagetreatmentforlimbthreateningdiabeticfootwoundsarandomizedcontrolledstudy
AT abdelatifm efficacyofanewlocallimbsalvagetreatmentforlimbthreateningdiabeticfootwoundsarandomizedcontrolledstudy
AT helmys efficacyofanewlocallimbsalvagetreatmentforlimbthreateningdiabeticfootwoundsarandomizedcontrolledstudy
_version_ 1718402552571101184